News | May 24, 2024
Merck to showcase advances in the science of cancer with new data presented at ASCO 2024
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Fluid bed processes: drying, granulating, and coating in just one product container
Highly effective preservation solutions ensuring the safety and protection of personal care products
Minister was briefed on the nationwide dengue situation
Take proper precautions and seek timely treatment!
PEEK brings a new quality to dental care for patients
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
From cancer research to diagnostic solutions
Subscribe To Our Newsletter & Stay Updated
